Invest in us
Following the initial injection of R500 million, there’s expected deployment over the first two years, with a further pipeline of over R2 billion. Our entity is value-focused and seeks to deliver traditional alternative asset-class returns while providing day-to-day liquidity, lower management costs, and higher transparency.
We also provide investors with alternative asset-class returns, through a diverse portfolio of other debt/equity securities in operating companies, which participate in a broad array of healthcare-specific sectors. Proceeds from capital raises and profits from the realisation of RH Bophelo’s investments will be re-invested, and therefore result in capital appreciation for investors.
For our investors
This section contains all the important documents that an investor or future investor may require.
